Back to SPRY overview

SPRY ARS Pharmaceuticals PE ratio, current and historical analysis

The current P/E ratio of SPRY cannot be calculated, as the latest EPS of -$0.52 is negative. The most recent PE ratio recorded for ARS Pharmaceuticals was 9.96 in September 2022.

SPRY PE ratio history

How has SPRY's PE ratio performed in the past
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

ARS Pharmaceuticals PE ratio by year

Year PE ratio Change
2023 N/A N/A
2022 N/A N/A
2021 N/A N/A
2020 N/A N/A
2019 N/A N/A
2018 N/A N/A

SPRY average PE ratio chart

What is the average PE ratio of SPRY for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

SPRY PE vs peers

What is SPRY's PE ratio compared to its peers
Stock name PE ratio Market cap
OLMA Olema Pharmaceuticals Inc N/A $644.36M
OMER Omeros Corp N/A $232.36M
OMGA Omega Therapeutics Inc N/A $116.38M
SPRY ARS Pharmaceuticals Inc N/A $754.81M

Frequently asked questions

What is ARS Pharmaceuticals's PE ratio?

The current price to earnings ratio of SPRY cannot be determined, as its EPS of -$0.52 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.